{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:32:35Z","timestamp":1790929955614,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>We studied the sera of patients with progressive systemic sclerosis (PSS) for elevated levels of soluble interleukin-2 receptor (sIL-2R), interleukin-2 (IL-2) and interleukin-4 (IL-4). We also measured IL-2, IL-4 and B cell growth factor (BCGF) activity in supernatants of peripheral blood mononuclear cells from the same patients. The finding of elevated serum sIL-2R and IL-2, and the increased levels of IL-2, IL-4 and BCGF activity in culture supernatants indicates that T lymphocyte hyperactivity likely play a major role in PSS. The failure to detect under our experimental conditions a direct proliferative effect of recombinant IL-2 on enriched normal B cells might suggest that IL-4 is the cytokine mainly responsible of the BCGF activity recovered in PSS supernatants.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05340.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T10:25:21Z","timestamp":1280226321000},"page":"368-372","source":"Crossref","is-referenced-by-count":64,"title":["Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis"],"prefix":"10.1093","volume":"81","author":[{"given":"G","family":"FAMULARO","sequence":"first","affiliation":[{"name":"Clinica Medica, University of L'Aquila, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"PROCOPIO","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Sperimentale, University of L'Aquila, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"GIACOMELLI","sequence":"additional","affiliation":[{"name":"Clinica Medica, University of L'Aquila, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"DANESE","sequence":"additional","affiliation":[{"name":"Clinica Medica II, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"SACCHETTI","sequence":"additional","affiliation":[{"name":"Clinica Medica, University of L'Aquila, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"PEREGO","sequence":"additional","affiliation":[{"name":"Clinica Medica II, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"SANTONI","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Sperimentale, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"TONIETTI","sequence":"additional","affiliation":[{"name":"Clinica Medica, University of L'Aquila, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713331725300_b1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1172\/JCI110579","article-title":"Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus","volume":"69","author":"Alcocer-Varela","year":"1982","journal-title":"J. clin. Invest."},{"key":"2022011713331725300_b2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00683884","article-title":"Differences in the production of and\/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases","volume":"4","author":"Alcocer-Varela","year":"1984","journal-title":"Rheumatol. Int."},{"key":"2022011713331725300_b3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1084\/jem.162.4.1319","article-title":"Purification to homogeneity of a high molecular weight human B cell growth factor, demonstration of a specific binding to activated B cells, and development of a monoclonal antibody to the factor","volume":"162","author":"Ambrus","year":"1985","journal-title":"J. exp. Med."},{"key":"2022011713331725300_b4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.4049\/jimmunol.139.5.1496","article-title":"Elevated titers of cell-free interleukin-2 receptor in serum of lupus mice","volume":"139","author":"Balderas","year":"1987","journal-title":"J. Immunol."},{"key":"2022011713331725300_b5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0161-5890(86)90147-1","article-title":"Regulation of interleukin-2 receptor expression and receptor release","volume":"23","author":"Diamantstein","year":"1986","journal-title":"Mol. Immunol."},{"key":"2022011713331725300_b6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0049-0172(87)90033-3","article-title":"Silicon and rheumatic diseases","volume":"2","author":"Endo","year":"1987","journal-title":"Semin. Arthritis Rheum."},{"key":"2022011713331725300_b7","first-page":"59","article-title":"Polyclonal B lymphocyte activation in progressive systemic sclerosis","volume":"29","author":"Famularo","year":"1989","journal-title":"J. clin. Lab. Immunol."},{"key":"2022011713331725300_b8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.1983.01650360003004","article-title":"Scleroderma. A model for fibrosis","volume":"119","author":"Fleischmajer","year":"1983","journal-title":"Arch. Dermatol."},{"key":"2022011713331725300_b9","first-page":"375","article-title":"Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy","volume":"69","author":"Freundlich","year":"1987","journal-title":"Clin. exp. Immunol."},{"key":"2022011713331725300_b10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/art.1780220815","article-title":"A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma","volume":"22","author":"Furst","year":"1979","journal-title":"Arthritis Rheum."},{"key":"2022011713331725300_b11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0090-1229(88)90060-8","article-title":"Mononuclear cell-fibroblast interactions in scleroderma","volume":"46","author":"Gonzalez-Amaro","year":"1988","journal-title":"Clin. Immunol. Immunopalhol."},{"key":"2022011713331725300_b12","first-page":"360","article-title":"Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis","volume":"80","author":"GraziaCifone","year":"1990","journal-title":"Clin. exp. Immunol."},{"key":"2022011713331725300_b13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.162.3.1111","article-title":"Expression of interleukin-2 receptors and binding of interleukin-2 by gamma interferon-induced human leukemic and normal monocytic cells","volume":"162","author":"Hermann","year":"1985","journal-title":"J. exp. Med."},{"key":"2022011713331725300_b14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.141.3.827","article-title":"Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus","volume":"141","author":"Huang","year":"1988","journal-title":"J. Immunol."},{"key":"2022011713331725300_b15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.1780280708","article-title":"Cellular immunity to collagen and laminin in scleroderma","volume":"28","author":"Huffstutter","year":"1985","journal-title":"Arthritis Rheum."},{"key":"2022011713331725300_b16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"Kahaleh","year":"1989","journal-title":"Ann. intern. Med."},{"key":"2022011713331725300_b17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1084\/jem.166.3.786","article-title":"Tumor necrosis factor alpha promotes the growth and differentiation of human B cells","volume":"166","author":"Kehrl","year":"1987","journal-title":"J. exp. Med."},{"key":"2022011713331725300_b18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1126\/science.3500512","article-title":"Lymphotoxin is an important T cell-derived growth factor for human B cells","volume":"238","author":"Kehrl","year":"1987","journal-title":"Science"},{"key":"2022011713331725300_b19","first-page":"242","article-title":"Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications","volume":"73","author":"Kitas","year":"1988","journal-title":"Clin. exp. Immunol."},{"key":"2022011713331725300_b20","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","article-title":"Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus","volume":"130","author":"Linker-Israeli","year":"1983","journal-title":"J. Immunol."},{"key":"2022011713331725300_b21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0090-1229(89)90140-2","article-title":"Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases","volume":"50","author":"Manoussakis","year":"1989","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2022011713331725300_b22","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.4049\/jimmunol.135.5.3298","article-title":"Purification of a human B cell growth factor","volume":"135","author":"Mehta","year":"1985","journal-title":"J. Immunol."},{"key":"2022011713331725300_b23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0090-1229(84)90195-8","article-title":"Interleukin-2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus","volume":"31","author":"Miyasaka","year":"1984","journal-title":"Clin. Immunol. Immunopalhol."},{"key":"2022011713331725300_b24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0090-1229(88)90119-5","article-title":"Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation","volume":"49","author":"Monroe","year":"1988","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2022011713331725300_b25","first-page":"156","article-title":"Activation, proliferation and differentiation of human B lymphocytes","volume-title":"Lymphokines","author":"Muraguchi","year":"1983"},{"key":"2022011713331725300_b26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00918743","article-title":"An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro","volume":"6","author":"Nelson","year":"1986","journal-title":"J. clin. Immunol."},{"key":"2022011713331725300_b27","first-page":"550","article-title":"Elevated serum levels of interleukin-2 receptor (IL-2R) and IL-2 in diffuse (DS) and limited scleroderma (LS)","volume-title":"Abstract Book of the VIIth International Congress of Immunology, Berlin July 30th-August 5th 1989","author":"Peter","year":"1989"},{"key":"2022011713331725300_b28","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.4049\/jimmunol.135.5.3264","article-title":"Non-cytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF)","volume":"135","author":"Procopio","year":"1985","journal-title":"J. Immunol."},{"key":"2022011713331725300_b29","first-page":"41","article-title":"Cytokines involved in activation, growth and differentiation of human B cells","volume":"1","author":"Romagnani","year":"1989","journal-title":"J. immunol. Res."},{"key":"2022011713331725300_b30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum."},{"key":"2022011713331725300_b31","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.4049\/jimmunol.137.12.3841","article-title":"The released interleukin 2 receptor binds interleukin 2 efficiently","volume":"137","author":"Rubin","year":"1986","journal-title":"J. Immunol."},{"key":"2022011713331725300_b32","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J. Immunol."},{"key":"2022011713331725300_b33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00916949","article-title":"Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"8","author":"Semenzato","year":"1988","journal-title":"J. clin. Immunol."},{"key":"2022011713331725300_b34","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/art.1780271107","article-title":"Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage","volume":"27","author":"Silver","year":"1984","journal-title":"Arthritis Rheum."},{"key":"2022011713331725300_b35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum."},{"key":"2022011713331725300_b36","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.141.8.2612","article-title":"Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition","volume":"141","author":"Symons","year":"1988","journal-title":"J. Immunol."},{"key":"2022011713331725300_b37","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.141.9.3043","article-title":"Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus","volume":"141","author":"Tanaka","year":"1988","journal-title":"J. Immunol."},{"key":"2022011713331725300_b38","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.126.4.1393","article-title":"A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. 1. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells","volume":"126","author":"Uchiyama","year":"1981","journal-title":"J. Immunol."},{"key":"2022011713331725300_b39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/art.1780310312","article-title":"Enhanced production of interleukin-2 in patients with progressive systemic sclerosis. Hyperactivity of CD4-positive T cells","volume":"31","author":"Umehara","year":"1988","journal-title":"Arthritis Rheum."},{"key":"2022011713331725300_b40","first-page":"2763","article-title":"Augmentation absolu et relative des cellules Leullb+ chez les malades atteints de sclerodermie generalisee","volume":"13","author":"Valentini","year":"1984","journal-title":"Presse Med."},{"key":"2022011713331725300_b41","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1084\/jem.160.5.1450","article-title":"Expression of interleukin-2 receptors on activated human B cells","volume":"160","author":"Waldmann","year":"1984","journal-title":"J. exp. Med."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05340.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/3\/368\/42217840\/j.1365-2249.1990.tb05340.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/3\/368\/42217840\/j.1365-2249.1990.tb05340.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T19:28:01Z","timestamp":1711654081000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/81\/3\/368\/6488816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05340.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1990,9]]},"published":{"date-parts":[[1990,9]]}}}